Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab.

Leard LE, Cho BK, Jones KD, Hays SR, Tope WD, Golden JA, Hoopes CW.

J Heart Lung Transplant. 2007 Dec;26(12):1340-4.

PMID:
18096489
[PubMed - indexed for MEDLINE]
2.

The role of cetuximab in the treatment of squamous cell cancer of the head and neck.

Burtness B.

Expert Opin Biol Ther. 2005 Aug;5(8):1085-93. Review.

PMID:
16050785
[PubMed - indexed for MEDLINE]
3.

Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.

Wong SF.

Clin Ther. 2005 Jun;27(6):684-94. Review.

PMID:
16117976
[PubMed - indexed for MEDLINE]
4.

Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.

Moon C, Chae YK, Lee J.

Exp Biol Med (Maywood). 2010 Aug;235(8):907-20. doi: 10.1258/ebm.2009.009181. Epub 2010 Jun 18. Review.

PMID:
20562132
[PubMed - indexed for MEDLINE]
5.

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.

Harding J, Burtness B.

Drugs Today (Barc). 2005 Feb;41(2):107-27. Review.

PMID:
15821783
[PubMed - indexed for MEDLINE]
6.

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.

Uribe P, Gonzalez S.

Pathol Res Pract. 2011 Jun 15;207(6):337-42. doi: 10.1016/j.prp.2011.03.002. Epub 2011 Apr 29. Review.

PMID:
21531084
[PubMed - indexed for MEDLINE]
7.

EGFR-targeting monoclonal antibodies in head and neck cancer.

Astsaturov I, Cohen RB, Harari PM.

Curr Cancer Drug Targets. 2006 Dec;6(8):691-710. Review.

PMID:
17168674
[PubMed - indexed for MEDLINE]
8.

Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.

Vokes EE, Chu E.

Oncology (Williston Park). 2006 Apr;20(5 Suppl 2):15-25. Review.

PMID:
16736979
[PubMed - indexed for MEDLINE]
9.

Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.

Jean GW, Shah SR.

Pharmacotherapy. 2008 Jun;28(6):742-54. doi: 10.1592/phco.28.6.742. Review.

PMID:
18503402
[PubMed - indexed for MEDLINE]
10.

The emerging role of cetuximab in head and neck cancer: a 2007 perspective.

Panikkar RP, Astsaturov I, Langer CJ.

Cancer Invest. 2008 Feb;26(1):96-103. doi: 10.1080/07357900701601002. Review.

PMID:
18181051
[PubMed - indexed for MEDLINE]
11.

EGFR-targeting monoclonal antibodies in head and neck cancer.

Astsaturov I, Cohen RB, Harari P.

Curr Cancer Drug Targets. 2007 Nov;7(7):650-65. Review.

PMID:
18045070
[PubMed - indexed for MEDLINE]
12.

The role of EGFR inhibitors in nonsmall cell lung cancer.

Ciardiello F, De Vita F, Orditura M, Tortora G.

Curr Opin Oncol. 2004 Mar;16(2):130-5. Review.

PMID:
15075904
[PubMed - indexed for MEDLINE]
13.

The efficacy of combined treatment with cetuximab (erbitux) and radiation therapy in patients with head and neck cancer.

Koukourakis G, Kouloulias V, Koukourakis M, Kouvaris J, Zacharias G, Gouliamos A.

J BUON. 2009 Jan-Mar;14(1):19-25. Review.

PMID:
19373942
[PubMed - indexed for MEDLINE]
14.

Cetuximab in advanced non-small cell lung cancer.

Govindan R.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4241s-4244s. Review.

PMID:
15217966
[PubMed - indexed for MEDLINE]
Free Article
15.

Cetuximab: from bench to bedside.

Vincenzi B, Zoccoli A, Pantano F, Venditti O, Galluzzo S.

Curr Cancer Drug Targets. 2010 Feb;10(1):80-95. Review.

PMID:
20088790
[PubMed - indexed for MEDLINE]
16.

Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.

Le Tourneau C, Siu LL.

Curr Opin Oncol. 2008 May;20(3):256-63. doi: 10.1097/CCO.0b013e3282f9b575. Review.

PMID:
18391623
[PubMed - indexed for MEDLINE]
17.

Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck.

Bernier J.

Nat Clin Pract Oncol. 2008 Dec;5(12):705-13. doi: 10.1038/ncponc1228. Epub 2008 Sep 30. Review.

PMID:
18825142
[PubMed - indexed for MEDLINE]
18.

Extending outcomes: epidermal growth factor receptor-targeted monoclonal antibodies in non-small-cell lung cancer.

Joy AA, Butts CA.

Clin Lung Cancer. 2009 Mar;10 Suppl 1:S24-9. doi: 10.3816/CLC.2009.s.004. Review.

PMID:
19362943
[PubMed - indexed for MEDLINE]
19.

Cetuximab in cancers of the lung and head & neck.

Kim ES, Vokes EE, Kies MS.

Semin Oncol. 2004 Feb;31(1 Suppl 1):61-7. Review.

PMID:
14981582
[PubMed - indexed for MEDLINE]
20.

Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy.

Machiels JP, Schmitz S.

Curr Opin Oncol. 2011 May;23(3):241-8. doi: 10.1097/CCO.0b013e328344f581. Review.

PMID:
21358328
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk